LivaNova (LIVN) Total Debt Growth (1y) (2016 - 2026)
Powered by 
Analysis
LivaNova (LIVN) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 12.29% |
| 10 | LivaNova | 4.51 Bn | 3.99 Bn | 273.67 Mn | -42.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.72% |
| Mar 31, 2026 | -51.27% |
| Dec 31, 2025 | -39.56% |
| Sep 30, 2025 | -19.71% |
| Jun 30, 2025 | -20.42% |
| Mar 31, 2025 | 9.98% |
| Dec 31, 2024 | 16.70% |
| Sep 30, 2024 | 6.92% |
| Jun 30, 2024 | 6.41% |
| Mar 31, 2024 | 14.09% |
| Dec 31, 2023 | 6.30% |
| Sep 30, 2023 | 7.71% |
| Jun 30, 2023 | 28.15% |
| Mar 31, 2023 | 21.51% |
| Dec 31, 2022 | -12.51% |
| Sep 30, 2022 | -8.36% |
| Jun 30, 2022 | -55.63% |
| Mar 31, 2022 | -30.28% |
| Dec 31, 2021 | -3.25% |
| Sep 30, 2021 | -8.68% |